Your session is about to expire
← Back to Search
STEPS Program for Autism
Study Summary
This trial will test an innovative program to help transition-age youth with ASD. It will involve stakeholders and be assessed for feasibility and impact.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 16 and 25 years old and have been diagnosed with ASD.My medication doses have not changed recently.I am between 16-25 years old with ASD and have a caregiver willing to participate. My medication is stable.The person who takes care of you is willing to be a part of the study.
- Group 1: STEPS
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
For whom is this clinical trial an appropriate option?
"In order to be considered for this research, applicants must have a diagnosed autism spectrum disorder, be between the ages of 16 and 25 years old and have a caregiver willing to participate. Furthermore, they should also not currently be taking any medication that could affect their results."
Is this exploration accepting enrollees at present?
"Clinicaltrials.gov reports that this medical trial is presently seeking to recruit patients, with the initial posting being on May 15th 2022 and latest edits made on October 11th 2022."
Is this research study accepting participants aged 50 or above?
"This trial is available to patients aged 16-25 given that they meet all other eligibility requirements."
How many subjects have enrolled in this clinical investigation?
"Affirmative. According to information available on clinicaltrials.gov, this study is currently recruiting individuals for participation. It was first published on May 15th 2022 and last modified October 11th of the same year. The single trial centre requires 25 subjects for enrollment."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger